Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients

Daniel Rukavina, Sanja Balen-Marunic, Gordana Rubesa, Petar Orlic, Ksenija Vujaklija, Eckhard R. Podack

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Perforin (P) is a cytolytic molecule expressed in the granules of cytolytic T cells and natural killer cells. Although cytotoxic cells have been implicated in graft rejection, no prospective clinical study has been published that examines the dynamics of perforin expressing cells in peripheral blood lymphocytes of transplanted patients. The cytofluorimetric assay developed in our laboratory previously for the simultaneous detection of intracellular perforin together with cell surface molecules was used for posttransplantation monitoring of patients, for the assessment of the efficiency of immunosuppressive treatment, and for the prediction of acute kidney transplant rejection and the stability of tolerance to long lived kidney transplants. Immunosuppression for the purpose of allotransplantation causes a decline in the number of perforin-expressing cells in peripheral blood. In contrast, in patients with clinical signs of acute rejection, the total number of perforin-expressing lymphocytes was increased in comparison with nonrejecting patients. Analyzing perforin-expressing subsets, rejection crises were accompanied by a relative decrease of perforin expression in the CD4+ subpopulation while increasing in the CD8+ subset. In the CD56+ and CD16+ NK subpopulations changes in perforin expression were mixed. In nonrejecting patients the ratio of perforin expression in CD4+ cells was high compared with CD8+ cells. Intensive therapy of acute rejection episodes with high doses of corticosteroids (methylprednisolonet [Solumedrol] bolus) strongly and significantly decreased the percentage of both, the subpopulations of perforin-positive T cells and the subpopulation of CD56+P+ NK cells. The lowest level of perforin expression, including low frequencies of perforin among CD8+ and CD4+ cells, was found in the group of patients tolerating transplanted kidneys for several years. These changes in perforin protein expression in peripheral blood can be used to discriminate between immunosuppressed patients who are immunologically quiescent and those who undergo transplant rejection. Our results confirm the hypothesis that cytotoxicity mediated by perforin may be an important effector mechanism in the rejection of allografted kidneys.

Original languageEnglish
Pages (from-to)285-291
Number of pages7
JournalTransplantation
Volume61
Issue number2
DOIs
StatePublished - Jan 27 1996
Externally publishedYes

Fingerprint

Perforin
Lymphocytes
Kidney
Graft Rejection
Transplant Recipients
Natural Killer Cells
Methylprednisolone Hemisuccinate
T-Lymphocytes
Physiologic Monitoring
Immunosuppressive Agents
Immunosuppression

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Rukavina, D., Balen-Marunic, S., Rubesa, G., Orlic, P., Vujaklija, K., & Podack, E. R. (1996). Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients. Transplantation, 61(2), 285-291. https://doi.org/10.1097/00007890-199601270-00021

Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients. / Rukavina, Daniel; Balen-Marunic, Sanja; Rubesa, Gordana; Orlic, Petar; Vujaklija, Ksenija; Podack, Eckhard R.

In: Transplantation, Vol. 61, No. 2, 27.01.1996, p. 285-291.

Research output: Contribution to journalArticle

Rukavina, D, Balen-Marunic, S, Rubesa, G, Orlic, P, Vujaklija, K & Podack, ER 1996, 'Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients', Transplantation, vol. 61, no. 2, pp. 285-291. https://doi.org/10.1097/00007890-199601270-00021
Rukavina, Daniel ; Balen-Marunic, Sanja ; Rubesa, Gordana ; Orlic, Petar ; Vujaklija, Ksenija ; Podack, Eckhard R. / Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients. In: Transplantation. 1996 ; Vol. 61, No. 2. pp. 285-291.
@article{6bae95618b734df39b568375896c57f8,
title = "Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients",
abstract = "Perforin (P) is a cytolytic molecule expressed in the granules of cytolytic T cells and natural killer cells. Although cytotoxic cells have been implicated in graft rejection, no prospective clinical study has been published that examines the dynamics of perforin expressing cells in peripheral blood lymphocytes of transplanted patients. The cytofluorimetric assay developed in our laboratory previously for the simultaneous detection of intracellular perforin together with cell surface molecules was used for posttransplantation monitoring of patients, for the assessment of the efficiency of immunosuppressive treatment, and for the prediction of acute kidney transplant rejection and the stability of tolerance to long lived kidney transplants. Immunosuppression for the purpose of allotransplantation causes a decline in the number of perforin-expressing cells in peripheral blood. In contrast, in patients with clinical signs of acute rejection, the total number of perforin-expressing lymphocytes was increased in comparison with nonrejecting patients. Analyzing perforin-expressing subsets, rejection crises were accompanied by a relative decrease of perforin expression in the CD4+ subpopulation while increasing in the CD8+ subset. In the CD56+ and CD16+ NK subpopulations changes in perforin expression were mixed. In nonrejecting patients the ratio of perforin expression in CD4+ cells was high compared with CD8+ cells. Intensive therapy of acute rejection episodes with high doses of corticosteroids (methylprednisolonet [Solumedrol] bolus) strongly and significantly decreased the percentage of both, the subpopulations of perforin-positive T cells and the subpopulation of CD56+P+ NK cells. The lowest level of perforin expression, including low frequencies of perforin among CD8+ and CD4+ cells, was found in the group of patients tolerating transplanted kidneys for several years. These changes in perforin protein expression in peripheral blood can be used to discriminate between immunosuppressed patients who are immunologically quiescent and those who undergo transplant rejection. Our results confirm the hypothesis that cytotoxicity mediated by perforin may be an important effector mechanism in the rejection of allografted kidneys.",
author = "Daniel Rukavina and Sanja Balen-Marunic and Gordana Rubesa and Petar Orlic and Ksenija Vujaklija and Podack, {Eckhard R.}",
year = "1996",
month = "1",
day = "27",
doi = "10.1097/00007890-199601270-00021",
language = "English",
volume = "61",
pages = "285--291",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients

AU - Rukavina, Daniel

AU - Balen-Marunic, Sanja

AU - Rubesa, Gordana

AU - Orlic, Petar

AU - Vujaklija, Ksenija

AU - Podack, Eckhard R.

PY - 1996/1/27

Y1 - 1996/1/27

N2 - Perforin (P) is a cytolytic molecule expressed in the granules of cytolytic T cells and natural killer cells. Although cytotoxic cells have been implicated in graft rejection, no prospective clinical study has been published that examines the dynamics of perforin expressing cells in peripheral blood lymphocytes of transplanted patients. The cytofluorimetric assay developed in our laboratory previously for the simultaneous detection of intracellular perforin together with cell surface molecules was used for posttransplantation monitoring of patients, for the assessment of the efficiency of immunosuppressive treatment, and for the prediction of acute kidney transplant rejection and the stability of tolerance to long lived kidney transplants. Immunosuppression for the purpose of allotransplantation causes a decline in the number of perforin-expressing cells in peripheral blood. In contrast, in patients with clinical signs of acute rejection, the total number of perforin-expressing lymphocytes was increased in comparison with nonrejecting patients. Analyzing perforin-expressing subsets, rejection crises were accompanied by a relative decrease of perforin expression in the CD4+ subpopulation while increasing in the CD8+ subset. In the CD56+ and CD16+ NK subpopulations changes in perforin expression were mixed. In nonrejecting patients the ratio of perforin expression in CD4+ cells was high compared with CD8+ cells. Intensive therapy of acute rejection episodes with high doses of corticosteroids (methylprednisolonet [Solumedrol] bolus) strongly and significantly decreased the percentage of both, the subpopulations of perforin-positive T cells and the subpopulation of CD56+P+ NK cells. The lowest level of perforin expression, including low frequencies of perforin among CD8+ and CD4+ cells, was found in the group of patients tolerating transplanted kidneys for several years. These changes in perforin protein expression in peripheral blood can be used to discriminate between immunosuppressed patients who are immunologically quiescent and those who undergo transplant rejection. Our results confirm the hypothesis that cytotoxicity mediated by perforin may be an important effector mechanism in the rejection of allografted kidneys.

AB - Perforin (P) is a cytolytic molecule expressed in the granules of cytolytic T cells and natural killer cells. Although cytotoxic cells have been implicated in graft rejection, no prospective clinical study has been published that examines the dynamics of perforin expressing cells in peripheral blood lymphocytes of transplanted patients. The cytofluorimetric assay developed in our laboratory previously for the simultaneous detection of intracellular perforin together with cell surface molecules was used for posttransplantation monitoring of patients, for the assessment of the efficiency of immunosuppressive treatment, and for the prediction of acute kidney transplant rejection and the stability of tolerance to long lived kidney transplants. Immunosuppression for the purpose of allotransplantation causes a decline in the number of perforin-expressing cells in peripheral blood. In contrast, in patients with clinical signs of acute rejection, the total number of perforin-expressing lymphocytes was increased in comparison with nonrejecting patients. Analyzing perforin-expressing subsets, rejection crises were accompanied by a relative decrease of perforin expression in the CD4+ subpopulation while increasing in the CD8+ subset. In the CD56+ and CD16+ NK subpopulations changes in perforin expression were mixed. In nonrejecting patients the ratio of perforin expression in CD4+ cells was high compared with CD8+ cells. Intensive therapy of acute rejection episodes with high doses of corticosteroids (methylprednisolonet [Solumedrol] bolus) strongly and significantly decreased the percentage of both, the subpopulations of perforin-positive T cells and the subpopulation of CD56+P+ NK cells. The lowest level of perforin expression, including low frequencies of perforin among CD8+ and CD4+ cells, was found in the group of patients tolerating transplanted kidneys for several years. These changes in perforin protein expression in peripheral blood can be used to discriminate between immunosuppressed patients who are immunologically quiescent and those who undergo transplant rejection. Our results confirm the hypothesis that cytotoxicity mediated by perforin may be an important effector mechanism in the rejection of allografted kidneys.

UR - http://www.scopus.com/inward/record.url?scp=0030057023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030057023&partnerID=8YFLogxK

U2 - 10.1097/00007890-199601270-00021

DO - 10.1097/00007890-199601270-00021

M3 - Article

C2 - 8600638

AN - SCOPUS:0030057023

VL - 61

SP - 285

EP - 291

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 2

ER -